Moderna and Lonza collaborate to manufacture mRNA vaccine against COVID-19
Collaboration goal to produce up to one billion doses per year, first batches expected to be manufactured at Lonza US in July 2020
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.